Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive
Thu, 05/16/24 - 11:41 am
Tags:
JNJ, M&A, Proteologix, bispecific antibodies
Biopharma M&A activity jumped 71% in Q1 2024
Medical Marketing and Media
Thu, 05/16/24 - 11:37 am
Tags:
M&A, Novo Nordisk, Catalent, Gilead Sciences, CymaBay Therapeutics, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx
Winners and Losers in Biopharma’s Q1 2024 Earnings Season
BioSpace
Wed, 05/15/24 - 11:30 am
Tags:
earnings, Amgen, AstraZeneca, Novo Nordisk, Biogen, Bristol Myers Squibb, JNJ
He invented a successful medical device as a student. Here's his advice for new grads
NPR
Tue, 05/14/24 - 11:42 am
Tags:
Abiomed, JNJ, Medtech, Impella
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Tags:
Big Pharma, Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, JNJ, Tecvayli, Merck, Vaxneuvance, AbbVie, Qulipta, AstraZeneca, Saphnelo, Novartis, Leqvio, Roche, Genentech, Vabysmo, Amgen, Evenity, Pfizer, Vyndaqel
Johnson & Johnson looks to offload remaining Kenvue stake in $3.75B deal
Fierce Pharma
Mon, 05/13/24 - 11:18 am
Tags:
JNJ, consumer health, spinoffs, Kenvue
BMS, J&J Losses Not the End of IRA Legal Battle
BioSpace
Wed, 05/8/24 - 11:08 am
Tags:
JNJ, Bristol Myers Squibb, Inflation Reduction Act, legal
Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
Reuters
Tue, 05/7/24 - 11:12 am
Tags:
Kenvue, earnings, JNJ, consumer health, spinoffs
J&J’s ‘Pretzel’ Drug-Device Combo Scores in Mid-Stage Bladder Cancer Study
BioSpace
Mon, 05/6/24 - 05:52 pm
Tags:
JNJ, clinical trials, TAR-200, drug-device combos, bladder cancer
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena
Mon, 05/6/24 - 11:28 am
Tags:
JNJ, clinical trials, Erleada, prostate cancer
As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL
Fierce Pharma
Thu, 05/2/24 - 11:31 am
Tags:
AbbVie, JNJ, Imbruvica, AstraZeneca, Calquence, mantle cell lymphoma
J&J advances $6.48 billion settlement of talc cancer lawsuits
Reuters
Wed, 05/1/24 - 11:16 pm
Tags:
JNJ, talc, legal, ovarian cancer, settlements
J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate
BioSpace
Mon, 04/29/24 - 10:56 pm
Tags:
Addex Therapeutics, JNJ, ADX71149, epilepsy, clinical trials
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters
Mon, 04/29/24 - 10:52 pm
Tags:
Bristol Myers Squibb, JNJ, Medicare, Inflation Reduction Act, legal
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche
Fierce Pharma
Wed, 04/24/24 - 08:50 am
Tags:
orphan drugs, Evaluate Pharma, JNJ, Vertex Pharmaceuticals, Roche
Inside J&J’s strategy to de-gender clinical trials
Pharma Voice
Tue, 04/23/24 - 10:33 am
Tags:
clinical trials, LGBTQ+, clinical trial diversity, JNJ
AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J
BioSpace
Mon, 04/22/24 - 11:45 am
Tags:
physicians, AbbVie, JNJ, Pfizer, immunology
‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tue, 04/16/24 - 10:07 pm
Tags:
JNJ, Medtech, M&A, Abiomed, Laminar, Shockwave Medical
J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
BioSpace
Tue, 04/16/24 - 11:19 am
Tags:
JNJ, earnings
Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Mon, 04/15/24 - 11:16 am
Tags:
Legend Biotech, Carvykti, mutliple myeloma, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.